For more than 10 years, partners including RTI International and the Schistosomiasis Control Initiative have supported Uganda’s Ministry of Health – ensuring all schistosomiasis endemic districts in the country are covered with life-saving medication and helping to prevent future morbidity in a generation of Ugandan children. In doing so, USAID is helping ensure that a healthy Ugandan population can contribute to their economy and lead their country to prosperity.
Nigeria’s Federal Ministry of Health has interrupted transmission of river blindness in two large states and as a result will stop mass drug administration (MDA) of ivermectin (Mectizan®) in 2018.
In recognition of the 10-year anniversary of the USAID NTD program, the Agency commissioned an independent evaluation to better understand how the program has contributed to achieving the World Health Organization (WHO) 2020 NTD goals and inform the future direction of the Agency NTD Program.
This two-page fact sheet explains how the USAID Neglected Tropical Diseases Program tackles the most prevalent neglected tropical diseases.
USAID looks forward to collaborating with the newly launched Fund to advance the elimination agenda, coordinating and co-investing in countries where USAID is currently providing support.
Bill Gates visits Tanzania to find out about how they mobilized their health systems to support mass drug administration to combat neglected tropical diseases.
U.S. Agency for International Development recognizes the distinguished career of Dr. Dirk Engels and in particular his enormous contribution and service in the fight against neglected tropical diseases. Dr. Engles retired on September 29, 2017.
On September 19th, The World Health Organization (WHO) congratulated the Kingdom of Cambodia and the Lao People’s Democratic Republic on eliminating trachoma as a public health problem.
On May 9th, 2017, the United States Agency for International Development (USAID) hosted over 50 public, private, and nonprofit organizations working or interested in neglected tropical diseases (NTDs) in a daylong technical consultation meeting organized by USAID’s NTD Division. Please read the executive summary of the technical consultation.
New data released by the World Health Organization (WHO) show a remarkable 63% increase in the number of people treated with an antibiotic for trachoma during the period 2014–2016, considerably improving prospects for the global elimination of the disease.
By training and deploying surgical supportive supervisors, the USAID-funded MMDP Project helps trichiasis surgeons continually improve, and ensures that patients receive the highest quality services possible. It’s just one way the MMDP Project supports countries in meeting their trachoma elimination goals.
The first-ever grantees of the African Researchers' Small Grants program were announced; winners will receive support to conduct NTD research in their home countries of Cameroon, Nigeria, Tanzania, and Togo.
CAPT Stephanie R. Bialek, Chief of the Parasitic Diseases Branch at the U.S. Centers for Disease Control and Prevention says we are closer than ever to beating NTDs.
WHO releases Fourth report on neglected tropical diseases: Integrating neglected tropical diseases in global health and development
The donor landscape has been initiated by the U.S. Agency for International Development (USAID) and the U.K. Department for International Development (DFID), both supporters of the World Health Organization’s 2020 goals to control or eliminate neglected tropical diseases (NTDs). This document was developed in response to the growing number of requests from the global NTD community to better understand the focus of donor contributions.
The UK announces a doubling of support to fight Neglected Tropical Diseases, such as trachoma, Guinea worm and river blindness, over the next 5 years.
After over a decade of persistent efforts, Togo has eliminated lymphatic filariasis – also known as elephantiasis – as a public health problem.
The USAID Neglected Tropical Diseases Program is celebrating 10 years of progress. This brochure features key moments of the USAID NTD Program’s 10 year history.
Through village-based, quality-focused surgery campaigns, the USAID-funded MMDP Project is bringing trichiasis sufferers relief, joy, and a new chance at life. Some might even call it magic.
USAID was among the original endorsers of the 2012 London Declaration on NTDs. This global declaration marks a key moment in USAID’s 10-year history in tackling NTDs.
With support from USAID, the African Research Network for Neglected Tropical Diseases is collaborating with the Coalition for Operational Research on Neglected Tropical Diseases to initiate the African Researchers’ Small Grants Program. A formal call for proposals is available here.
Rob Henry, a senior public health adviser with USAID's Neglected Tropical Disease (NTD) program, shares Drazen's outlook: "I think 2016 was an excellent year," he says.
Earlier this year, the U.S. Agency for International Development marked 10 years of work on NTDs and launched a new five-year strategy to eliminate trachoma, the world's leading cause of preventable blindness, and lymphatic filariasis, a painful and disfiguring parasitic infection transmitted by mosquitoes.
The UK launched two reviews on December 1, 2016, that establish how the UK will champion an open, modern and innovative approach to development that will effectively tackle the global challenges of the 21st century while delivering the best results for the world’s poorest: Raising the standard: The Multilateral Development Review 2016 and Rising to the challenge of ending poverty: The Bilateral Development Review 2016.
Neglected tropical diseases, or NTDs, are a group of debilitating illnesses that affect the poorest and most marginalized communities in the world. They can kill -- NTDs cause about 150,000 deaths every year -- but their main impact is to sicken and disable. Approximately 1.6 billion people are affected by one or more NTD.
On November 15, 2016, the World Health Organization (WHO) acknowledged the elimination of trachoma as a public health problem in Morocco.
Across the globe, there are 200 million people at risk of trachoma, a preventable, blinding infectious disease. More than three million people are in need of immediate surgery to avoid blindness due to trichiasis, a manifestation of trachoma that causes eyelashes to turn inward, scraping the cornea with each blink. We blink 19,000 times a day.
After over a decade of efforts, Cambodia, Cook Islands, Niue and Vanuatu have eliminated lymphatic filariasis—also known as elephantiasis—as a public health problem.
The U.S. Agency for International Development (USAID) today announced new partnerships to help countries eliminate and control neglected tropical diseases (NTDs).
Wita Larasati and her husband ventured to their local mosque. They were answering their mayor’s personal call for all eligible residents to take treatment for lymphatic filariasis (LF), a painful and disfiguring parasitic infection.
Customs officials in Africa may be a bit surprised when they look inside several boxes due to arrive soon from the United States But the unusual cargo – a life-size model of a man's groin – is for a good cause.
In Mozambique, almost 7 million people are at risk of losing their sight from trachoma, an eye infection that is the world’s leading cause of blindness.
The result was HEAD START, a brown-eyed, silicone mannequin that gazes patiently upward as students swath it in sterile drapes and cut into its orbicularis muscle, tarsal plate and conjunctiva. Crucial to the design are the dummy’s removable eyelids, which allow trainees to examine the precision of their work.
USAID joins the Kuwait Fund, the U.K. Department for International Development (DFID), the World Bank, the END Fund, the Arab Bank for Economic Development in Africa, MSD, Sightsavers, and other organizations, which are together providing a cumulative $11.4 million in seed funding.
Preschool-aged children like Anwar, who often live in extreme poverty, are most at risk of contracting Chlamydia trachomatis, a bacterium that spreads through eye and nose discharge, hand contact and flies. With repeated episodes of infections over many years, it causes the eyelashes to turn inward, scraping the cornea, causing great pain and eventually leading to blindness.
The USAID-funded Morbidity Management and Disability Prevention (MMDP) Project, managed by Helen Keller International, has a new website aimed at providing information on the program’s goals and objectives as well as highlighting progress.
The problem in middle-income countries — many which have the resources to treat NTDs — is that there can be a lack of political will to extend those resources to people most in need, according to Angela Weaver, senior technical adviser at USAID’s NTD program.
You won't be able to see any of the 20 million or so creatures in the National Parasite Collection for a while because displays take a few years to create. In the meantime, here are some of the collection's most fascinating creepy-crawlies, chosen by Anna J. Phillips, research zoologist at the Smithsonian National Museum of Natural History.
Dr. Kumaraswami influenced so much and meant a lot to so many in the NTD community, from the young students he mentored to leading researchers in the global NTD arena. He no doubt made a huge impact on the poorest and most vulnerable populations, particularly those suffering from lymphatic filariasis.
TRICHIASIS, the last stage of an infection called trachoma, rarely hits the headlines. That is because it does not kill. It does, however, blind. More than 2million people suffer, half of whom have lost their vision.
A ground breaking 3-year disease-mapping project has shown that 100 million people are at risk of blindness from trachoma.
The Global NGO Deworming Inventory complements the WHO Preventive Chemotherapy Databank by collecting district-level data on NGO-administered deworming treatments. The Inventory is a collaborative project of WHO, the STH Coalition, and the Global Schistosomiasis Alliance, in partnership with Children Without Worms (CWW).
The Third Progress Report of the London Declaration on Neglected Tropical Diseases (NTDs) "Country Leadership and Collaboration on Neglected Tropical Diseases," released June 25, 2015, notes that significant global progress has been made in raising the visibility of NTDs and in introducing and expanding national NTD programs.
We are delighted to announce that Dr. Adrian Hopkins, Mectizan Donation Program Director, has been appointed Member of the Order of the British Empire (MBE) in recognition of his humanitarian service in Africa.
USAID's NTD team, key partners, and representatives from NTD programs of 10 USAID-supported countries recently met to discuss critical strategies to eliminate neglected tropical diseases.
The national science academies of the G7 countries are urging their respective heads of government to take action on neglected tropical diseases.
For almost a decade, USAID has supported the delivery of preventive drug treatments for neglected tropical diseases around the globe.
USAID's Assistant Administrator for Global Health, Dr. Ariel Pablos-Méndez, and staff from across the Agency’s Global Health Bureau celebrate the One Billion and Counting Campaign in Washington, D.C. Visit the photo gallery to browse all the photos from the event.
Are there opportunities out there for public-private collaboration on NTDs? The Ghana NTD Programme certainly thinks so. Learn how it’s working with the country’s Society of Private Medical and Dental Practitioners (SPMDP) to collaborate more effectively.
The government of Nepal joined the global community to celebrate USAID’s landmark achievement in supporting 1 billion treatments for NTDs in 2014.
A Photo Gallery was launched in recognition of USAID’s One Billion and Counting Campaign: Accelerating Action to Eliminate NTDs at the American Cultural Center in Maputo, Mozambique.
Indonesia honored two unsung heroes as part of the USAID One Billion Celebration during their 2014 Stakeholders’ Meeting held in Jakarta, Indonesia, on August 11, 2014.
USAID celebrates its support of the delivery of 1 billion NTD treatments that are helping more than 465 million people in 25 countries.